Skip to content
Research Article Open access CC BY 3.0

Hypercalcemia in Malignancy; the Second Great Masquerader

Adam H. Miller, Marcelo Sandoval, Jayne Viets-UpChurch, Arun Jacob, Maggie Q. Ma

International Journal of Medical and Pharmaceutical Case Reports · pp. 1–11 · Published 17 Jul 2014

10.9734/IJMPCR/2014/11240

Abstract

Hypercalcemia in malignancy can present with metabolic derangement, generalized weakness, altered mental status, renal compromise, cardiac dysrhythmias including atrial fibrillation and bradycardia, abdominal pain and/or shortness of breath amongst many other clinical manifestations. We present three cases of hypercalcemia in patients with malignancies; followed by discussion of hypercalcemia including etiology, clinical presentation and treatment.

Hypercalcemia malignancy cancer clinical manifestations management, dysrhythmia.

References (24)

  1. 1 Hypercalcemia Associated with Cancer [DOI]
  2. 2 Interpretation of Serum Calcium in Patients with Abnormal Serum Proteins [DOI]
  3. 3 Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials [DOI]
  4. 4 Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates [DOI]
  5. 5 A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer. [DOI]
  6. 6 Primary dexamethasone treatment of multiple myeloma [DOI]
  7. 7 Narrative Review: Furosemide for Hypercalcemia: An Unproven yet Common Practice [DOI]
  8. 8 Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas [DOI]
  9. 9 The Renal Drug Handbook [DOI]
  10. 10 Mechanisms and treatment of hypercalcemia of malignancy [DOI]
  11. 11 Oxford Handbook of Palliative Care [DOI]
  12. 12 Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates [DOI]
  13. 13 Hypercalcemia in Cancer Patients: Pathobiology and Management [DOI]
  14. 14 Denosumab for Patients With Persistent or Relapsed Hypercalcemia of Malignancy Despite Recent Bisphosphonate Treatment [DOI]
  15. 15 Hypercalcemia-induced ST-segment elevation mimicking acute myocardial infarction [DOI]
  16. 16 COMPARISON OF AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE, MITHRAMYCIN, AND CORTICOSTEROIDSICALCITONIN IN TREATMENT OF CANCER-ASSOCIATED HYPERCALCAEMIA [DOI]
  17. 17 Medical treatment of hypercalcaemia [DOI]
  18. 18 Oncological emergencies: clinical importance and principles of management [DOI]
  19. 19 Palliative Medicine: Evidence-Based Symptomatic and Supportive Care for Patients with Advanced Cancer
  20. 20 Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: a randomized study [DOI]
  21. 21 Potentiation of calcitonin by corticosteroids during the treatment of the hypercalcaemia of malignancy [DOI]
  22. 22 Hypercalcemia associated with parathyroid hormone-related protein produced by B-cell type primary malignant lymphoma of the kidney [DOI]
  23. 23 Understanding Laboratory Investigations for Nurses and Health Professionals
  24. 24 Metastatic bone disease and tumour-induced hypercalcaemia: treatment options [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

20

Page views

0

PDF downloads

3

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.